Pharmacy Chain 36.6 (MOEX: APTK)
Russia
· Delayed Price · Currency is RUB 12.50
-0.00 (-0.03%)
At close: Jul 8, 2022
Pharmacy Chain 36.6 Income Statement
Financials in millions RUB. Fiscal year is January - December.
Millions RUB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Revenue | 60,351 | 59,048 | 44,104 | 39,267 | 36,524 | 44,664 | Upgrade
|
| Revenue Growth (YoY) | 25.00% | 33.88% | 12.32% | 7.51% | -18.22% | -7.44% | Upgrade
|
| Cost of Revenue | 40,295 | 39,049 | 29,147 | 25,860 | 26,666 | 33,690 | Upgrade
|
| Gross Profit | 20,056 | 19,999 | 14,957 | 13,407 | 9,858 | 10,974 | Upgrade
|
| Selling, General & Admin | 16,206 | 15,931 | 14,235 | 12,584 | 12,394 | 8,200 | Upgrade
|
| Other Operating Expenses | -479 | -444 | -456 | -571 | -420 | -39 | Upgrade
|
| Operating Expenses | 15,840 | 15,681 | 13,997 | 12,160 | 12,154 | 15,000 | Upgrade
|
| Operating Income | 4,216 | 4,318 | 960 | 1,247 | -2,296 | -4,026 | Upgrade
|
| Interest Expense | -4,122 | -4,241 | -3,239 | -4,634 | -4,035 | -6,396 | Upgrade
|
| Interest & Investment Income | 237 | 391 | 412 | 83 | 30 | 5 | Upgrade
|
| Currency Exchange Gain (Loss) | -386 | 14 | 30 | -202 | 170 | -229 | Upgrade
|
| Other Non Operating Income (Expenses) | -337 | -251 | -212 | -181 | -21 | -849 | Upgrade
|
| EBT Excluding Unusual Items | -392 | 231 | -2,049 | -3,687 | -6,152 | -11,495 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -4,743 | Upgrade
|
| Gain (Loss) on Sale of Assets | 94 | 107 | -2 | 36 | 51 | -481 | Upgrade
|
| Asset Writedown | 64 | 73 | 609 | 3,008 | -2,145 | -6,038 | Upgrade
|
| Pretax Income | -234 | 411 | -1,442 | -643 | -8,246 | -22,757 | Upgrade
|
| Income Tax Expense | -67 | 188 | -492 | 349 | 216 | 220 | Upgrade
|
| Earnings From Continuing Operations | -167 | 223 | -950 | -992 | -8,462 | -22,977 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | 7,343 | -393 | - | Upgrade
|
| Net Income to Company | -167 | 223 | -950 | 6,351 | -8,855 | -22,977 | Upgrade
|
| Net Income | -167 | 223 | -950 | 6,351 | -8,855 | -22,977 | Upgrade
|
| Net Income to Common | -167 | 223 | -950 | 6,351 | -8,855 | -22,977 | Upgrade
|
| Shares Outstanding (Basic) | 7,630 | 7,630 | 7,630 | 6,807 | 4,884 | 2,331 | Upgrade
|
| Shares Outstanding (Diluted) | 7,630 | 7,630 | 7,630 | 6,807 | 4,884 | 2,331 | Upgrade
|
| Shares Change (YoY) | -0.01% | - | 12.10% | 39.36% | 109.57% | - | Upgrade
|
| EPS (Basic) | -0.02 | 0.03 | -0.12 | 0.93 | -1.81 | -9.86 | Upgrade
|
| EPS (Diluted) | -0.02 | 0.03 | -0.12 | 0.93 | -1.81 | -9.86 | Upgrade
|
| Free Cash Flow | 8,844 | 5,901 | 2,528 | -5,058 | -3,604 | -9,841 | Upgrade
|
| Free Cash Flow Per Share | 1.16 | 0.77 | 0.33 | -0.74 | -0.74 | -4.22 | Upgrade
|
| Gross Margin | 33.23% | 33.87% | 33.91% | 34.14% | 26.99% | 24.57% | Upgrade
|
| Operating Margin | 6.99% | 7.31% | 2.18% | 3.18% | -6.29% | -9.01% | Upgrade
|
| Profit Margin | -0.28% | 0.38% | -2.15% | 16.17% | -24.24% | -51.44% | Upgrade
|
| Free Cash Flow Margin | 14.65% | 9.99% | 5.73% | -12.88% | -9.87% | -22.03% | Upgrade
|
| EBITDA | 5,664 | 5,724 | 2,130 | 2,264 | -1,409 | -2,894 | Upgrade
|
| EBITDA Margin | 9.38% | 9.69% | 4.83% | 5.77% | -3.86% | -6.48% | Upgrade
|
| D&A For EBITDA | 1,448 | 1,406 | 1,170 | 1,017 | 887 | 1,132 | Upgrade
|
| EBIT | 4,216 | 4,318 | 960 | 1,247 | -2,296 | -4,026 | Upgrade
|
| EBIT Margin | 6.99% | 7.31% | 2.18% | 3.18% | -6.29% | -9.01% | Upgrade
|
| Effective Tax Rate | - | 45.74% | - | - | - | - | Upgrade
|
| Advertising Expenses | - | 368 | 213 | 166 | 193 | 227 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.